Event
Exploring Oncology Precision Medicine Landscape
View all IQVIA events

Precision medicine is rapidly gaining prominence as a mainstream treatment approach in oncology. Coupled with the rise of precision medicine, oncology has also seen biomarker tests not just entering the mainstream but also shifting the way decisions are made.

Join us as we explore current trends and insights with the evolving landscape of precision medicine and biomarker testing and its impact on oncology markets across different tumor types and geographies.

3 key takeaways:

  • Understand the complex market landscape of precision medicine therapies and biomarker testing.
  • Explore how biomarkers are tracked using IQVIA’s syndicated oncology offering
  • Explore genomics in the immuno-oncology landscape
Speakers:

Vladimir Bonevski
Associate Director, Global Oncology Product & Strategy, IQVIA

Kriti Jindal, M.S. (Pharm.)
Client Service Manager, Global Oncology, IQVIA

Lien Lybaert
Chief Development Officer, myNEO Therapeutics

Related solutions

Contact Us